BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20388114)

  • 1. PET with non-standard nuclides.
    Hao G; Singh AN; Liu W; Sun X
    Curr Top Med Chem; 2010; 10(11):1096-112. PubMed ID: 20388114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unconventional nuclides for radiopharmaceuticals.
    Holland JP; Williamson MJ; Lewis JS
    Mol Imaging; 2010 Feb; 9(1):1-20. PubMed ID: 20128994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image quality with non-standard nuclides in PET.
    Laforest R; Liu X
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):151-8. PubMed ID: 18043539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in copper radiopharmaceuticals.
    Hao G; Singh AN; Oz OK; Sun X
    Curr Radiopharm; 2011 Apr; 4(2):109-21. PubMed ID: 22191650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.
    Welch MJ; Laforest R; Lewis JS
    Ernst Schering Res Found Workshop; 2007; (62):159-81. PubMed ID: 17172155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation of triple coincidences in PET.
    Cal-González J; Lage E; Herranz E; Vicente E; Udias JM; Moore SC; Park MA; Dave SR; Parot V; Herraiz JL
    Phys Med Biol; 2015 Jan; 60(1):117-36. PubMed ID: 25479147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative small animal PET imaging with nonconventional nuclides.
    Liu X; Laforest R
    Nucl Med Biol; 2009 Jul; 36(5):551-9. PubMed ID: 19520296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-Assisted Design of Peptide-Based Radiotracers.
    Patamia V; Zagni C; Brullo I; Saccullo E; Coco A; Floresta G; Rescifina A
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
    Dollé F
    J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceutical chemistry for positron emission tomography.
    Li Z; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for consistency in the manufacture of PET radiopharmaceuticals.
    Finn RD
    Ann Nucl Med; 1999 Dec; 13(6):379-82. PubMed ID: 10656270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.
    Chacko AM; Divgi CR
    Med Chem; 2011 Sep; 7(5):395-412. PubMed ID: 21711220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
    Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
    Ghesani M; Depuey EG; Rozanski A
    Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decay data and production yields of some non-standard positron emitters used in PET.
    Qaim SM
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals.
    Taggart MP; Tarn MD; Esfahani MM; Schofield DM; Brown NJ; Archibald SJ; Deakin T; Pamme N; Thompson LF
    Lab Chip; 2016 Apr; 16(9):1605-16. PubMed ID: 27044712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.